Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Chinese Clinical Oncology|May 10, 2019
Inflammation and development of pancreatic ductal adenocarcinomaJuanjuan Shi, Jing XueISA Transactions|March 11, 2019
Non-dominated solution set based on time-frequency infograms for local damage detection of rotating machinesXingxing Jiang, Juanjuan Shi, Weiguo Huang, et al.Current Pharmaceutical Design|May 26, 2015
PPARδ signaling regulates colorectal cancerMengli You, Shuping Yuan, Juanjuan Shi, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 25, 2016
Inhibitor of growth-4 is a potential target for cancer therapyShuping Yuan, Jianhua Jin, Juanjuan Shi, et al.BMC Immunology|May 30, 2026
The LncRNA MIAT acts as a sponge for miR-942-5p to exacerbate the inflammation and oxidative stress in macrophages during sepsis-associated liver injuryJuanjuan Shi, Zhiyuan Liu, Juan Liu, et al.Journal of Cancer Research and Clinical Oncology|August 22, 2016
INGs are potential drug targets for cancerRunyun Zhang, Jianhua Jin, Juanjuan Shi, et al.Journal of Cellular Biochemistry|December 5, 2024
PPARδ Antagonist Inhibited CD47 Expression and PhagocytosisYilei Guo, Bibimaryam Khan, Juanjuan Shi, et al.European Journal of Pharmacology|February 24, 2025
GW501516 facilitated tumor immune escape by inhibiting phagocytosisJing Qian, Yilei Guo, Bibimaryam Khan, et al.European Journal of Pharmacology|May 1, 2025
TBB inhibits CK2/PD-L1/EGFR pathway-mediated tumor progressionSuning Che, Yao Zhang, Huihui Xu, et al.Medical Oncology (Northwood, London, England)|April 23, 2024
Ferroptosis is an effective strategy for cancer therapyAfrasyab Khan, Yu Huo, Yilei Guo, et al.Pageof 11